Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Alberta
$27,000.00
Determining the Role of Neutrophil-Derived Activin A in Experimental Autoimmune Encephalomyelitis
FY 2025-26
Summary
Multiple sclerosis (MS) is a neurodegenerative, chronic inflammatory disease of the central nervous system (CNS). Although treatments are available, MS remains a major cause of functional disability. Activin-A is a multifunctional protein with various immune modulating effects, implicated in both MS progression and remission. Circulating immune cells known as neutrophils, have a wide range of functions that have also been implicated in MS pathogenesis. Our previous work has identified neutrophils as major producers of Activin-A during neuroinflammation, with little production by other cell types. This finding suggests that neutrophils and Activin-A are intimately connected and have a fundamental role in the progression and subsidence of MS. Understanding Activin-A in MS and when it helps versus causes harm is vital to furthering our understanding of the disease. Experimental Autoimmune Encephalomyelitis (EAE) will be used as an animal model for MS. To examine the role of Activin-A, mice with neutrophil-specific knockouts of the gene encoding Activin-A (Inhba) will be used. Mice will be immunized with EAE and monitored for disease progression and pain behavior. This will be followed up with CNS tissue analysis. To understand how Activin-A shapes the inflammatory CNS environment, scRNA-seq will be conducted on Activin-A deficient and control EAE mice during remission and relapse. These findings are expected to define the role of neutrophils and Activin-A throughout EAE disease progression. This will bolster our understanding of immune-mediated mechanisms that cause MS pathology, and may identify a novel treatment target to improve the quality of life for individuals with MS.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573091
Name
Causgrove Sydney H
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the Role of Neutrophil-Derived Activin A in Experimental Autoimmune Encephalomyelitis
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Activin-A; Cd8+; Demyelination; Experimental Autoimmune Encephalomyelitis (Eae); Inflammation; Multiple Sclerosis; Neurodegeneration; Neuroimmunology; Neutrophils; Pain; Regulatory T Cells); T-Cells (Cd4+; Th1; Th17
Abstract
Multiple sclerosis (MS) is a neurodegenerative, chronic inflammatory disease of the central nervous system (CNS). Although treatments are available, MS remains a major cause of functional disability. Activin-A is a multifunctional protein with various immune modulating effects, implicated in both MS progression and remission. Circulating immune cells known as neutrophils, have a wide range of functions that have also been implicated in MS pathogenesis. Our previous work has identified neutrophils as major producers of Activin-A during neuroinflammation, with little production by other cell types. This finding suggests that neutrophils and Activin-A are intimately connected and have a fundamental role in the progression and subsidence of MS. Understanding Activin-A in MS and when it helps versus causes harm is vital to furthering our understanding of the disease. Experimental Autoimmune Encephalomyelitis (EAE) will be used as an animal model for MS. To examine the role of Activin-A, mice with neutrophil-specific knockouts of the gene encoding Activin-A (Inhba) will be used. Mice will be immunized with EAE and monitored for disease progression and pain behavior. This will be followed up with CNS tissue analysis. To understand how Activin-A shapes the inflammatory CNS environment, scRNA-seq will be conducted on Activin-A deficient and control EAE mice during remission and relapse. These findings are expected to define the role of neutrophils and Activin-A throughout EAE disease progression. This will bolster our understanding of immune-mediated mechanisms that cause MS pathology, and may identify a novel treatment target to improve the quality of life for individuals with MS.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Causgrove, Sydney H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~